Literature DB >> 25681486

Inflammatory markers in ST-elevation acute myocardial infarction.

Ignacio M Seropian1, Chiara Sonnino2, Benjamin W Van Tassell3, Luigi M Biasucci4, Antonio Abbate5.   

Abstract

After acute myocardial infarction, ventricular remodeling is characterized by changes at the molecular, structural, geometrical and functional level that determine progression to heart failure. Inflammation plays a key role in wound healing and scar formation, affecting ventricular remodeling. Several, rather different, components of the inflammatory response were studied as biomarkers in ST-elevation acute myocardial infarction. Widely available and inexpensive tests, such as leukocyte count at admission, as well as more sophisticated immunoassays provide powerful predictors of adverse outcome in patients with ST-elevation acute myocardial infarction. We review the value of inflammatory markers in ST-elevation acute myocardial infarction and their association with ventricular remodeling, heart failure and sudden death. In conclusion, the use of these biomarkers may identify subjects at greater risk of adverse events and perhaps provide an insight into the mechanisms of disease progression. © The European Society of Cardiology 2015.

Entities:  

Keywords:  Inflammation; ST-elevation acute myocardial infarction; biological markers; ventricular remodeling

Mesh:

Substances:

Year:  2015        PMID: 25681486     DOI: 10.1177/2048872615568965

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  21 in total

Review 1.  The NLRP3 inflammasome in acute myocardial infarction.

Authors:  Stefano Toldo; Antonio Abbate
Journal:  Nat Rev Cardiol       Date:  2017-11-16       Impact factor: 32.419

2.  Profiling the Evolution of Inflammatory Response and Exploring Its Prognostic Significance in Acute Myocardial Infarction: The First Step to Establishing Anti-Inflammatory Strategy.

Authors:  Hung-Ju Lin; Tzung-Dau Wang
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

3.  A Novel Clinical Score for Differential Diagnosis Between Acute Myocarditis and Acute Coronary Syndrome - The SAlzburg MYocarditis (SAMY) Score.

Authors:  Moritz Mirna; Lukas Schmutzler; Albert Topf; Brigitte Sipos; Lukas Hehenwarter; Uta C Hoppe; Michael Lichtenauer
Journal:  Front Med (Lausanne)       Date:  2022-06-09

4.  Effect of IL-1 Blockade With Anakinra on Heart Failure Outcomes in Patients With Anterior Versus Nonanterior ST Elevation Myocardial Infarction.

Authors:  Marco Giuseppe Del Buono; Juan Ignacio Damonte; Juan Guido Chiabrando; Roshanak Markley; Jeremy Turlington; Cory R Trankle; Le Kang; Giuseppe Biondi-Zoccai; Benjamin W Van Tassell; Antonio Abbate
Journal:  J Cardiovasc Pharmacol       Date:  2022-06-01       Impact factor: 3.271

5.  Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.

Authors:  Antonio Abbate; George F Wohlford; Marco Giuseppe Del Buono; Juan Guido Chiabrando; Roshanak Markley; Jeremy Turlington; Dinesh Kadariya; Cory R Trankle; Giuseppe Biondi-Zoccai; Michael J Lipinski; Benjamin W Van Tassell
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2022-08-11

6.  Arrhythmic Recurrence and Outcomes in Patients Hospitalized With First Episode of Electrical Storm.

Authors:  Juan Ignacio Damonte; Marco Giuseppe Del Buono; Georgia K Thomas; James Mbualungu; Bennett Clark; Rocco Antonio Montone; Daniel H Berrocal; Tamas S Gal; Le Kang; Juan Lu; Benjamin Van Tassell; Jayanthi Koneru; Thomas C Crawford; Kenneth A Ellenbogen; Antonio Abbate; Jordana Kron
Journal:  Am J Cardiol       Date:  2022-03-30       Impact factor: 3.133

Review 7.  Impact of diabetes on outcomes of cardiogenic shock: A systematic review and meta-analysis.

Authors:  Chao Luo; Feng Chen; Lingpei Liu; Zuanmin Ge; Chengzhen Feng; Yuehua Chen
Journal:  Diab Vasc Dis Res       Date:  2022 Sep-Oct       Impact factor: 3.541

Review 8.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

9.  Combined biomarker testing for the prediction of left ventricular remodelling in ST-elevation myocardial infarction.

Authors:  Sebastian Johannes Reinstadler; Hans-Josef Feistritzer; Martin Reindl; Gert Klug; Agnes Mayr; Johannes Mair; Werner Jaschke; Bernhard Metzler
Journal:  Open Heart       Date:  2016-09-20

10.  Usefulness of the delta neutrophil index to predict 30-day mortality in patients with ST segment elevation myocardial infarction.

Authors:  Taeyoung Kong; Tae Hoon Kim; Yoo Seok Park; Sung Phil Chung; Hye Sun Lee; Jung Hwa Hong; Jong Wook Lee; Je Sung You; Incheol Park
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.